Systemic Sclerosis Clinical Trials in Lille
8 recruitingLille, France
Showing 1–8 of 8 trials
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Systemic Sclerosis (SSc)
argenx81 enrolled74 locationsNCT06655155
Recruiting
Phase 2
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals200 enrolled127 locationsNCT06470048
Recruiting
Phase 1
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
Rheumatoid ArthritisSystemic Lupus ErythematosusSystemic Sclerosis+1 more
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company270 enrolled54 locationsNCT05869955
Recruiting
Phase 2
Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
Digital Ulcers in Systemic Sclerosis
Topadur Pharma AG15 enrolled5 locationsNCT06954597
Recruiting
Phase 2
Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.
Systemic Sclerosis
University Hospital, Toulouse32 enrolled7 locationsNCT04356755
Recruiting
Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis
Systemic Sclerosis
University Hospital, Lille40 enrolled1 locationNCT05273138
Recruiting
Phase 2
Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis
Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris74 enrolled46 locationsNCT04789850
Recruiting
Not Applicable
Deployment o the Multidisciplinary Prospective Cohort Imminent
Severe AsthmaMultiple SclerosisAtopic Dermatitis+6 more
University Hospital, Lille2,200 enrolled1 locationNCT04334031